Skip to main content

Table 2 Mean differences in daily steps and accelerometer wear time between baseline and 6 months and baseline and 12 months for each intervention group

From: Process evaluation of the Sophia Step Study- a primary care based three-armed randomized controlled trial using self-monitoring of steps with and without counseling in prediabetes and type 2 diabetes

 

Multicomponent group A

Mean change

(95% CI) (n)

Single component group B

Mean change

(95% CI) (n)

Control Group C

Mean change

(95% CI) (n)

Daily steps

baseline- 6 months

941 (227, 1655) (n = 40)

990 (145, 1836) (n = 43)

− 506 (− 1118, 107) (n = 37)

Wear time (min)

baseline- 6 months

12.6 (− 19.5, 44.8) (n = 40)

11.0 (−4.8, 26.8) (n = 43)

14.8 (−11.0, 40.6) (n = 37)

Daily steps

baseline- 12 months

31 (− 507, 570) (n = 46)

144 (−566, 853) (n = 39)

−890 (− 1485, − 294) (n = 39)

Wear time (min)

baseline- 12 months

− 10.1 (− 29.3, 9.0) (n = 46)

−0.7 (− 21.8, 20.1) (n = 39)

8.6 (− 14.2, 31.4) (n = 39)